ArticleBMC infectious diseases2024

Feasibility, safety and effectiveness of prednisolone and vitamin B1, B6, and B12 in patients with post-COVID-19-syndrome (PreVitaCOV) - protocol of a randomised, double-blind, placebo-controlled multicentre trial in primary care (phase IIIb).

Caroline Tengelmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.